Creatol, an oxidative product of creatinine in hemodialysis patients

Free Radical Research

Volumn 32, Issue 1, 2000, Pages 85-92

  Tomida, Chie ^a   Aoyagi, Kazumasa ^a   Nagase, Sohji ^a   Gotoh, Michihiro ^a   Yamagata, Kunihiro ^b   Takemura, Katsumi ^c   Koyama, Akio ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Hitachi   (Japan)

^c Kamitsuga General Hospital   (Japan)

Author keywords

Creatol; Hemodialysis; Hydroxyl radical; Methylguanidine

Indexed keywords

CREATININE; CREATOL; HYDROXYL RADICAL; METHYLGUANIDINE; PARATHYROID HORMONE; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PLASMA CLEARANCE; TREATMENT OUTCOME;

EID: 0033986997     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715760000300091     Document Type: Article

References (16)

1. K. Nakamura and K. Ienaga (1990). Creatol (5-hydroxycreatinine), a new toxin candidate in uremic patients. Experientia, 46, 470-472.
2. K. Nakamura, K. Ienaga, T. Yokozawa, N. Fujitsuka and H. Oura (1991). Production of methylguanidine from creatinine via creatol by active oxygen species: Analyses of the catabolism in vitro. Nephron, 58, 42-46.
3. S. Giovannetti, M. Biagi, P.L. Balestri, R. Navalesi, P. Giagnoni, A. deMatteis, P. Ferro-Milone and C. Perffetti (1969). Uremic-like syndrome in dogs chronically intoxicated with methylguanidine and creatinine. Clinical Science, 36, 445-452.
4. S. Giovannetti, P.L. Balestri and G. Barsotti (1973). Methylguanidine in uremia. Archives of Internal Medicine, 131, 709-713.
5. G. Barsotti, G. Bevilacqua, E. Morelli, P. Cappeli, P.L. Balestri and S. Giovannetti (1975). Toxicity arising from guanidine compounds: Role of methylguanidine as a uremic toxin. Kidney International, 7, S299-S301.
6. R. Sorrentino and A. Pinto (1997). The increase in blood pressure induced by inhibition of nitric oxide syntheses in anesthetized Wistar rats is inversely related to basal blood pressure value. Journal of Cardiovascular Pharmacology, 29(5), 599-604.
7. K. Aoyagi, S. Nagase, M. Narita and S. Tojo (1987). Role of active oxygen on methylguanidine synthesis in isolated rat hepatocytes. Kidney International, 22, S229-S233.
8. K. Aoyagi, S. Nagase, K. Takemura, S. Ohba and M. Narita (1992). Dipyridamole decreased urinary excretion of methylguanidine increased by puromycin aminonucleoside in vivo. In Guanidino Compounds in Biology and Medicine. (Eds. P.P. De Deyn, B. Marescau, V. Stalon and I.A. Qureshi) John Libbey & Company Ltd. London. pp. 309-313.
9. M. Sakamoto, K. Aoyagi, S. Nagase, T. Ishikawa, K. Takemura and M. Narita (1989). Methylguanidine synthesis by active oxygen generated by stimulated human neutrophils. Japanese Journal of Nephrology, 21(8), 851-858 (in Japanese).
10. K. Takemura, K. Aoyagi, S. Nagase, M. Sakamoto, T. Ishikawa and M. Narita (1992). Effect of hyperbaric oxygen therapy on urinary methylguanidine excretion in patients with or without renal failure. In Guanidino Compounds in Biology and Medicine. (Eds. P.P. De Deyn, B. Marescau, V. Stalon and I.A. Qureshi) John Libbey & Company Ltd. London. pp. 301-307.
11. Y. Kinoshita, S. Takahashi and M. Yanai (1992). Methylguanidine kinetics during oral active vitamin D pulse therapy for secondary hyperparathyroidism. Japanese Journal of Nephrology, 24(2), 163-169 (in Japanese).
12. M. Ishizaki, H. Kitamura, K. Suzukai and E. Miyashita (1989). Effect of camostat on free radical activity in hemodialysis patients. Biomedical Research, 10(Suppl. 1), 179-184.
13. ε-(carboxymethyl)lysine in blood from maintenance hemodialysis patients may contribute to dialysis-related amyloidosis. Kidney International, 54, 1357-1366.
14. S. Nagase, K. Aoyagi, M. Narita and S. Tojo (1985). Biosynthesis of methylguanidine in isolated rat hepatocytes and in vivo. Nephron, 40, 470-475.
15. K. Nakamura and K. Ienaga (1992). The stability of creatol, an intermediate in the production of methylguanidine from creatinine and its analysis in physiological fluids. In Guanidino Compounds in Biology and Medicine. (Eds. P.P. De Deyn, B. Marescau, V. Stalon and I.A. Qureshi) John Libbey & Company Ltd. London. pp. 329-331.
16. K. Nakamura, K. Ienaga, K. Nakano, M. Nakai, Y. Nakamura, G. Hasegawa, M. Sawada, M. Kondo, H. Mori and T. Kanatsuna (1994). Creatol, a creatinine metabolite, as a useful determinant of renal function. Nephron, 66, 140-146.